Genospace

About:

Genospace is a medicine software platform that genomics is driving the development of precision medicine.

Twitter/X: GENOSPACE

Top Investors: Thomson Reuters

Description:

Genospace is a medicine software platform that genomics is driving the development of precision medicine. Their mission is to deliver the platform that makes biomedical data useful and usable by everyone. Genospace has built a comprehensive platform for precision medicine to enable interpretation, analysis, reporting, and collaboration on high-dimensional genomic and other biomedical data. With specific applications supporting research, development, pathology, and clinical care, many of the most advanced precision medicine organizations are powered by Genospace. The platform was founded in 2011 and is headquartered in Cambridge, Massachusetts, United States

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)genospace.com

Founders:

John Quackenbush, Mick Correll

Number of Employees:

11-50

Last Funding Date:

2014-08-07

IPO Status:

Private

Industries: